Cargando…
Cancer risk in Korean patients with gout
Autores principales: | Lai, Shih-Wei, Liu, Chiu-Shong, Hwang, Bing-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925939/ https://www.ncbi.nlm.nih.gov/pubmed/34666431 http://dx.doi.org/10.3904/kjim.2021.242 |
Ejemplares similares
-
Sodium-glucose cotransporter-2 inhibitors use and the risk of gout: a systematic review and meta-analysis
por: Lai, Shih-Wei, et al.
Publicado: (2023) -
The risk of ischemic cerebrovascular disease associated with benzbromarone use in gout people: A retrospective cohort study in Taiwan
por: Lai, Shih-Wei, et al.
Publicado: (2023) -
Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2022) -
Cancer risk in Korean patients with gout
por: Oh, Yoon-Jeong, et al.
Publicado: (2022) -
Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database
por: Kim, Ji-Won, et al.
Publicado: (2018)